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Abstract
Ca2+ signaling plays important roles during both axonal and dendritic growth. Yet, whether and how
Ca2+ rises may trigger and contribute to the development of long range cortical connections remains
largely unknown. Here we demonstrate that two separate limbs of CaMK kinase (CaMKK) - CaMKI
cascades, CaMKK-CaMKIα and CaMKK-CaMKIγ, critically coordinate axonal and dendritic
morphogenesis of cortical neurons, respectively. The axon-specific morphological phenotype
required a diffuse cytoplasmic localization and a strikingly α-isoform-specific kinase activity of
CaMKI. Unexpectedly, treatment with muscimol, a GABAA receptor agonist, selectively stimulated
elongation of axons but not of dendrites, and the CaMKK-CaMKIα cascade critically mediated this
axonogenic effect. Consistent with these findings, during early brain development, in vivo
knockdown of CaMKIα significantly impaired the terminal axonal extension, and thereby perturbed
the refinement of the interhemispheric callosal projections into the contralateral cortices. Our findings
thus indicate a novel role for the GABA-driven CaMKK-CaMKIα cascade as a mechanism critical
for accurate cortical axon pathfinding, an essential process which may contribute to fine-tuning the
formation of interhemispheric connectivity during the perinatal development of the central nervous
system.
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Introduction
The formation of cortical neural circuits requires precisely controlled development of axons
and dendrites. While the molecular mechanisms underlying axon guidance in the central
nervous system (CNS) has been intensively studied (Tessier-Lavigne and Goodman, 1996;
Dickson, 2002), the intracellular signaling and cytoskeletal remodeling mechanisms implicated
in the precise extension and targeting of axonal arbors still remain largely unsolved.
Ca2+ plays a central role in the regulation of neuronal morphogenesis. It is believed that there
is an elevated optimal range for the intracellular Ca2+ concentration that supports maximal
neurite outgrowth in various types of neurons (Kater et al., 1988; Gomez and Zheng, 2006).
Ca2+/calmodulin-dependent protein kinases (CaMKs), a major Ca2+-dependent kinase family,
are good candidates as potential downstream effectors of calcium elevation in neurons
(Soderling and Stull, 2001; Hudmon and Schulman, 2002). While the essential role of CaMKII
subfamily members in neuronal plasticity has been shown, much less is known about the
function of the CaMKI/IV subfamily which forms several distinct kinase cascades downstream
of CaMKKα and/or CaMKKβ (Soderling, 1999; Hook and Means, 2001; Hudmon and
Schulman, 2002; Bito and Takemoto-Kimura, 2003). The CaMKI family includes 4 isoforms:
α (Nairn and Greengard, 1987), β/Pnck (Yokokura et al., 1997), γ/CL3 (Takemoto-Kimura et
al., 2003) and δ/CKLiK (Ishikawa et al., 2003). Recently, a few number of reports from several
laboratories, including ours, have started to suggest, in vitro, that CaMKI activity may
participate in the regulation of neuronal morphology such as growth cone motility (Wayman
et al., 2004), neurite outgrowth (Schmitt et al., 2004; Uboha et al., 2007), activity-dependent
growth of dendrites (Wayman et al., 2006; Takemoto-Kimura et al., 2007), and stabilization
of spines (Saneyoshi et al., 2008). However, evidence based on materials from genetically
engineered animals is still scarce, and in vivo validation of such findings is still much awaited.
Furthermore, in spite of the heavy expression of all CaMKI isoforms in the developing
forebrain, there is yet little information as to what kinds of endogenous activity or extracellular
ligands may influence the activity of CaMKI, during a perinatal period when only spontaneous
Ca2+ transients are generated, and when synaptic activity-driven Ca2+-mobilization is still
missing.
We previously reported that a dendritic raft-anchored CaMK, CaMKIγ/CL3, plays an essential
role in dendritic growth downstream of BDNF (Takemoto-Kimura et al., 2007). However, the
exact context in which other CaMKI isoforms might contribute to neuronal morphogenesis
remained obscure.
Here we show genetic and pharmacogenetic evidence which demonstrate that two separate
limbs of CaMKK-CaMKI cascades, CaMKK-CaMKIα and CaMKK-CaMKIγ, critically
coordinate axonal and dendritic morphogenesis of immature cortical neurons, respectively.
Furthermore, we found that activation of GABAA receptors promoted axonal growth via the
CaMKK-CaMKIα pathway. During perinatal brain development, in vivo knockdown of
CaMKIα significantly impaired the terminal elongation of callosal axon projections in the
somatosensory cortex. Taken together, our data suggest that a GABA-driven CaMK cascade
may play a critical role in activity-regulated refinement of cortical axon wiring.
Materials and Methods
Construction of expression plasmids and RNA interference vectors
For RNAi experiments, short hairpin RNA (shRNA) vectors, co-expressing mRFP1 as a
morphological tracer, were constructed essentially as described (Takemoto-Kimura et al.,
2007). To create pSUPER-shCaMKIα and pSUPER-shCaMKIα#2, two complementary 60-bp
oligonucleotides carrying antisense and sense sequences for CATTGTAGCCCTGGATGAC
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(19-bp, corresponding to nucletides 231-249 of mouse CaMKIα) and
GATCAAGCACCCCAACATT (19-bp, corresponding to nucletides 216-234 of mouse
CaMKIα), respectively, were subcloned into the pSuper+mRFP1 plasmid backbone. pSUPER-
shNega was generated similarly except that an artificial 19-mer sequence
(ATCCGCGCGATAGTACGTA) was used as a target as described (Takemoto-Kimura et al.,
2007). This sequence was based upon a commercially available negative control siRNA
sequence (B-Bridge International), and we confirmed that it had no significant identity to any
known mammalian gene based on a BLAST search. Silent mutations were introduced into the
shRNA target sequence of EGFP-tagged wildtype and mutant CaMKIα cDNAs to generate
shRNA-resistant constructs (pEGFP-CaMKIαres and related constructs). Short-hairpin RNA
interference vectors against CaMKIα, CaMKIγ/CL3, and CaMKIV (shCaMKIα, shCaMKIγ/
CL3, and shCaMKIV) selectively suppressed expression of GFP-CaMKIα, GFP-CaMKIγ/
CL3, GFP-CaMKIV, respectively (Suppl. Fig. 2A, B). An antibody against CaMKIV (BD
Transduction Laboratories) also confirmed these results. The potency of the knockdown was
estimated to be about 70-80%, based on the reduction of overexpressed GFP-tagged proteins
in Western blot analyses (Suppl. Fig. 2B). In keeping with this, and consistent with a
transfection efficiency of >50% in our electroporation, we also detected a target-specific
decrease of 40~50% in the amount of endogenous mRNA using a Real-Time PCR System
(LightCycler 1.5, Roche Diagnostics) (Suppl. Fig. 2C).
Rat CaMKIα cDNA (Takemoto-Kimura et al., 2003) was inserted into pEGFPC1 vector (BD
Clontech) to generate pEGFP-CaMKIα. The expression vector for a constitutively active form,
pEGFP-CaMKIαCA (286IHQS to 286EDDD, F307A) was created from pEGFPCaMKIα by
site-directed mutagenesis. Similarly, a point mutation was introduced to generate pEGFP-
CaMKIαK49A. pCAG-EGFP-CaMKIγ/CL3 was as described (Takemoto-Kimura et al.,
2007). CaMKKβ wildtype and V269F cDNA (Tokumitsu et al., 2003) (a kind gift from Dr.
Hiroshi Tokumitsu, Kagawa University, Japan) was subcloned into pEGFPC3. Mouse
CaMKIβ and CaMKIδ cDNAs were obtained from the German RZPD gene collection and
RIKEN Genomic Science Center, respectively, and inserted into pEGFPC1 vector to generate
pEGFP-CaMKIβ and pEGFP-CaMKIδ All constructs were verified by sequencing.
Gene targeting, neuronal culture and pharmacology
All animal experiments in this study were carried out in accordance with regulations and
guidelines for the care and use of the experimental animals of the University of Tokyo, and
approved by the institutional review committee of University of Tokyo Graduate School of
Medicine.
CaMKK-α-KO mice were described before (Blaeser et al., 2006). CaMKK-β-KO mice were
produced similarly by deleting exon 2 (where the ATG starts) through exon 6 of the CaMKK-
β gene. A detailed characterization of CaMKK-β-KO mice will be described elsewhere
(Blaeser, Chatila et al., under preparation). CaMKK-α- and CaMKK-β-KO mice were crossed
to produce CaMKKα/β-double knockout (DKO) mice, The targeting strategy of CaMKIγ/CL3-
KO mice was as described before (Takemoto-Kimura et al., 2007).
Dissociated cortical neurons were prepared and cultured from embryonic-day-19 Sprague-
Dawley rats, or embryonic-day-17 C57BL/6 mice (wildtype as well as mutant mice),
essentially as described previously (Takemoto-Kimura et al., 2007). In brief, dissected cortices
were incubated for 10 min with 10 mg/ ml trypsin type XI (Sigma) plus 0.5 mg/ml DNase I
type IV (Sigma) at room temperature and mechanically dissociated in Hanks solution (pH 7.4)
(Sigma) with 0.5 mg/ml DNase I type IV and 12 mM MgSO4 Cortical neurons were transfected
immediately after dissociation by electroporation using a Nucleofector (Amaxa Biosystems),
plated onto poly-L-Lysine-coated 12 mm coverslips, glass-bottom dishes (Mat-Tek) or 6-well
dish (BD Biosciences), and maintained in minimum essential medium (Invitrogen) containing
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5 g/L glucose, 0.2 g/L NaHCO3, 0.1 g/L transferrin (Calbiochem), 2 mM GlutaMAX-I
(Invitrogen), 25 μg/ml insulin (Sigma), B-27 supplement (Invitrogen), and 10% fetal bovine
serum. Cultures were maintained in 5% CO2 at 37°C.
For inhibition and stimulation experiments, KN-93 (Calbiochem), STO-609 (TOCRIS),
mevastatin (Wako, Japan), muscimol (TOCRIS), or BDNF (generously provided by Dainippon
Sumitomo Pharma Co., Ltd., Osaka, Japan, by courtesy of Dr. Chikao Nakayama) were added
to the medium of cultured neurons expressing mRFP1 at 6 h after plating at the final
concentration of 10 μM (KN-93), 2.6 μM (STO-609), 10 μM (mevastatin), 1 μM (muscimol)
and 50 ng/ml (BDNF), respectively. Bath application was performed by dissolving the reagents
in one-half volume of the conditioned culture medium, and by mixing this gently with the
remaining half of the original medium in the dish. No medium change was done onwards till
fixation.
Immunocytochemistry, morphometric analyses, and visualization of raft-targeted proteins
For morphometric analysis, cortical neurons were transfected immediately after dissociation
by electroporation using Nucleofector and plated onto 12 mm poly-L-Lysine-coated coverslips
at the density of 5 × 105 cells (rats) or 7.5 × 105 cells (mice) per coverslip in 24-well plates.
Dissociated cultures of rat and mouse cortical neurons and all measurements (axonal and
dendritic length, axonal tip numbers) were performed at 2 days in vitro essentially as described
(Takemoto-Kimura et al., 2007). Images of neuronal morphologies were captured based on
immunoreactivities against GFP, mRFP1 or mCherry, using the Olympus BX51 microscopy
system with a 20 x objective. Dendrites and axons were identified by standard morphological
criteria as described (Takemoto-Kimura et al., 2007), and only neurons which possessed one
clearly classifiable axon and one or more dendrites, were analyzed. All quantitative analyses
were performed by an observer blinded to the identity of the transfected constructs, genotypes
of transgenic mice, or treated drugs.
Immunostaining was carried out as described (Bito et al., 1996; Nonaka et al., 2006; Takemoto-
Kimura et al., 2007). A rabbit anti-DsRed antibody (Takara, Japan) was used for quantitative
morphometric analyses of RNAi, rescue and forced expression experiments, and a rat anti-GFP
antibody (Nacalai Tesque, Japan) was used to detect coexpressed constructs. An anti-GM130
antibody (BD Transduction Laboratories) was used as a Golgi marker. As secondary
antibodies, Alexa 488-, Alexa 594- conjugated anti-mouse, anti-rabbit and anti-rat IgG
antibodies (Molecular Probes) were employed. Fluorescent images were taken by a confocal
laser microscopy system (LSM 510META-V3.2, Carl Zeiss) built on an inverted microscope
(Axiovert 200M, Carl Zeiss) with the 40x objective (Plan-Neofluar 40x/NA 1.3, oil, Carl
Zeiss), or using a CCD camera-based imaging analysis system (an Olympus BX51 equipped
with a DP-70 camera). Visualization of raft-targeted proteins was carried out as described
(Takemoto-Kimura et al., 2007).
Western blot analysis
For Western blot analysis, cortical neurons were transfected with pSUPERshNega or pSUPER-
shCaMKIα by electroporation using a Nucleofector and plated at a density of 5 × 106 cells in
a 6-well dish. At 2 DIV, the cells were lysed in lysis buffer containing 50 mM Tris-HCl (pH
6.8), 2% SDS, and 10% glycerol. A rabbit anti-CaMKIα antibody (Uezu et al., 2002) was used
(a kind gift from Drs. Kohji Fukunaga and Jiro Kasahara, Tohoku University, Japan).
Chemiluminescence detection was performed using horseradish perioxidase-conjugated anti-
rabbit IgG and ECL-Plus reagent (Amersham Biosciences).
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Calcium imaging
Fluorescent calcium imaging was performed essentially as described previously (Furuyashiki
et al., 2002; Takemoto-Kimura et al., 2007). Twenty-four hours after plating, cortical neurons
on glass-bottom dishes were loaded with Fluo-4/AM (2.5 μM, Dojindo laboratories,
Kumamoto, Japan) for 30 min at room temperature. After wash, cells were incubated at 37 °
C in a stage CO2 chamber (Tokai Hit Co., Ltd, Shizuoka, Japan) equipped on an
LSM510META (Carl Zeiss). After baseline recording, a medium containing 20 × muscimol
(final concentration 1 μM) was gently bath-applied. Fluorescence changes in the cell bodies
of individual cells were analyzed using Metamorph or Image J software, and data are expressed
as ΔF/Fo.
In utero electroporation. data acquisition and quantification of the terminal arborization of
callosal axons
In utero electroporation was performed as described previously (Mizuno et al. 2007). Equal
amount of pSUPER-vectors (2 μg/μl) and pCAG-EGFP (2 μg/μl) were mixed together with a
dye Fast Green (0.05%, Wako, Japan) for injection into the lateral ventricle. The postnatal
brains (P16) were fixed by transcardial perfusion of 4 % PFA in 0.1 M phosphate buffer
followed by overnight immersive fixation in 4% PFA in PBS and then transferred to 30%
sucrose in PBS for 1-2 days at 4 °C. Serial coronal brain sections were prepared at 50 μm
thickness by a cryostat (HM560, Microm), and every one section out of 4 were immunostained.
Sections were permeabilized in 0.3% Triton X- 100 in PBS and then blocked in 5% normal
goat serum, 1% BSA, and 0.3% Triton X- 100 in PBS followed by fluorescent immunostaining
of EGFP. Sections were counterstained with DAPI (Molecular Probes). Quantitative analyses
were performed and compared using the utmost posterior section of the stained sets that
included the corpus callosum.
Confocal images were taken (LSM 510META-V3.2, Carl Zeiss) with a 10x objective (Plan-
Neofluar 10x/NA 0.3, air, Carl Zeiss) with 10 μm optical sectioning. Z projection images taken
at 512 × 512 pixels were acquired by average projection mode and background was subtracted,
and the intensity was normalized by maximal intensity in the white matter. For one dimensional
fluorescence intensity profile analysis in Fig. 7C, a rectangular zone (nominal width set at 100
pixels) was drawn along the vertical axis from the pial surface to the white matter and the
average pixel intensity projected onto the vertical axis was calculated. To quantify the
impairment of the cortical wiring in Fig. 7D, average intensity in a rectangle region (100 pixels
in width) in the cortex was divided by that of in the white matter. Three to 5 pups were used
for quantification. All calculations were performed using Metamorph software (Ver. 7,
Molecular Devices).
Statistical analyses
Statistical analyses were run separately for axonal and dendritic datasets throughout our study,
while using scattered diagrams of paired data of axonal and dendritic lengths (“orthogonal
plots”). Statistical analyses were performed using Prism 4.0 (GraphPad Software). Student’s
t test was used for comparisons of two groups. One-or two-way analysis of variance (ANOVA)
with post hoc Tukey-Kramer or Bonferroni test was used for factorial analysis between more
than three groups. Kolmogorov-Smirnov test was applied to Fig. 1C, D. All data are shown as
mean ± standard error of mean (SEM), unless otherwise mentioned, and shaded regions in
orthogonal plots graphically depict the zone of mean ± 2*SEM on both axes to facilitate the
evaluation of the phenotypes.
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Results
CaMKK pathway regulates axonal and dendritic growth during early stages of cortical
development
We previously reported that, a dendritic raft-anchored CaMKIγ/CL3 (Takemoto-Kimura et al.,
2003) plays an essential role in dendritic growth downstream of BDNF during the
morphological maturation of cortical neurons (Takemoto-Kimura et al., 2007). As 4 distinct
CaMKI isoforms (α, β, γ/CL3 and δ) and CaMKIV are activated by upstream CaMK kinases
(CaMKK)-α and -β, we sought to test how potently neuritogenesis was disturbed in cultured
cortical neurons generated from CaMKKα/β-double knockout (DKO) mice. To specifically
identify the genotype contribution to either axonal or dendritic growth, we orthogonally plotted
the dendritic length (i.e. total length of all dendritic processes) and axonal length (i.e. total
length of all axonal processes including branches) for each GFP-expressing cortical neuron
blindly chosen from multiple fields of view (Fig. 1A, B and Supplemental Fig. 1). While
cortical neurons from CaMKIγ/CL3 knockout mice revealed a strikingly dendrite-specific
deficit (Fig. 1A-D), we found that both axons and dendrites were significantly shortened in
cortical neurons from DKO mice, as compared to neurons from wild-type (WT) mice (Fig.1A-
F). Exposure to KN-93, which blocks all CaMK species (CaMKII, CaMKI, CaMKIV, and
CaMKK), also reduced both total axonal and dendritic lengths (Fig. 1G, H). Specific blockade
of the CaMKKs, using STO-609, a selective inhibitor for CaMKKs (Tokumitsu et al. 2002),
resulted in a quantitatively similar impairment (Fig. 1G, H). Together, these genetical and
pharmacological experiments clearly demonstrated that CaMKK-mediated CaMK cascades
played critical roles both in axonogenesis and dendritogenesis of immature cortical neurons,
consistent with a prior work on other cell types (Wayman et al., 2004). Furthermore, our data
pointed to the presence of a selective CaMKK-CaMK cascade which strongly supported
cortical axonal growth in a manner that was distinct from the dendritic contribution of
CaMKIγ.
Suppression of CaMKIα expression specifically impairs axonal but not dendritic growth
In order to identify which of CaMKI or CaMKIV isoform(s) was involved in regulation of the
axonal growth, we designed several short hairpin-type pSUPER vectors which were targeted
to specific isoforms of the CaMKI/IV subfamily members. In this RNAi experiment, we also
coexpressed a PGK promoter-driven mRFP1 as a morphological tracer. In a control
experiment, polarized cortical neurons grown for 48 h typically grew 5 ~ 6 dendrites and a
single axon. Knockdown using an shCaMKIα vector was prominent enough such that even an
overexpressed GFP-CaMKIα became barely detectable 48 h after transfection, while the
control mRFP1 expression level remained unchanged (Fig. 2A). Strong suppression of
endogenous CaMKIα expression in shCaMKIα-transfected neurons was also demonstrated by
Western blot analysis using an anti-CaMKIα antibody (Fig. 2B). A lack of cross-knockdown
effects across α-, γ- CaMKI isoforms and CaMKIV was verified (Supplemental Fig. 2).
Under these conditions, shCaMKIα-treated neurons showed unchanged dendritic growth, but
had a markedly shorter axon (Fig. 2C, D). Under the same conditions, in contrast, CaMKIγ/
CL3 knockdown specifically blocked dendritic, but not axonal, outgrowth (Fig. 2E and
(Takemoto-Kimura et al., 2007)), while CaMKIV knockdown had no effect (Fig. 2E). The
striking specificity in CaMKIα’s axonal phenotype was replicated even when axonal growth
was measured under conditions in which shCaMKIα-transfected neurons were kept in
suspension culture for an extended period (48 h) prior to plating, to ensure a maximized
knockdown efficiency (Supplemental Fig. 3). The impairment in axonal growth observed in
CaMKIα-diminished neurons was rescued by expression of an shCaMKIα-resistant WT-
CaMKIα (WTres), but not by that of an shCaMKIα-resistant kinase-inactive CaMKIα
(K49Ares), demonstrating the requirement of the kinase activity of CaMKIα (Fig. 2F). Taken
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together, our results strongly implicated the CaMKK-CaMKIα cascade as a critical player in
the control of cortical axonal growth.
Two separate CaMKK-CaMKI cascades control cortical axonal and dendritic growth
In keeping with this robust selectivity in the knockdown experiments, forced expression of
either one of the 4 CaMKI isoforms revealed that total axonal length was stimulated only by
an increase in CaMKIα, while dendrite growth was promoted only by CaMKIγ/CL3 expression
(Fig. 3A, B). No change in primary axon number was detected in CaMKIα-overexpressing
neurons, suggesting that CaMKIα did not act on axon specification per se (data not shown).
Most critically, expression of a constitutively active CaMKIα (CaMKIαCA), was sufficient to
rescue the axonal deficit, but without altering dendritic atrophy, in cortical neurons from DKO
mice (Fig. 3C) or in WT neurons treated with STO-609 (Fig. 3D). However, forced expression
of CaMKIαWT, which enzymatically remains inactive in the absence of CaMKK activity, had
no effect in either of these backgrounds (Fig. 3C, D). In a parallel experiment, both axonal and
dendritic defects in WT neurons treated with STO-609 were rescued by transfection of a
STO-609-resistant CaMKKβ V269F mutant (Tokumitsu et al., 2003) (Fig. 3E).
Taken together, these data strongly implicated the CaMKK-CaMKIα and CaMKK-CaMKIγ
cascades as parallel pathways acting independently in the promotion of axonal and dendrite
growth, respectively, in cultured cortical neurons.
Both localization and kinase specificity of CaMKIα play important roles in CaMKIα-dependent
axonal growth
Our data, so far, suggested that the axonogenic action of CaMKIα manifested in a manner that
was completely orthogonal and independent to the dendritogenic effect mediated by
CaMKIγ/CL3, in spite of a high degree of structural identity (71% amino acid identity in the
catalytic domain sequences). What then discriminated the distinct function of these two
kinases?
To identify the molecular determinants involved in axonogenic and dendritogenic selectivity
of the CaMKK-CaMKI cascades, we generated CaMKIα/γ chimeras such that each kinase
domain was paired with either cytosolic or Golgi / raft localization signals in the C-terminus
(Fig. 4A and (Takemoto-Kimura et al., 2007)). We then tested their potencies to rescue the
defect due to knockdown of endogenous CaMKIα. As expected, forced expression of an
shCaMKIα-resistant WT-CaMKIα (Iαres) rescued the axonal impairment in CaMKIα
knockdown neurons (Fig. 4B). The WT-CaMKIγ/CL3 (Iγ), however, promoted dendritic
growth without showing any effect on axonal deficit. CaMKIα is believed to be freely
diffusible. On the other hand, the C-terminal region of CaMKIγ/CL3 is lipidified by prenylation
and palmitoylation, targeting it preferentially into lipid rafts which are highly abundant in
dendrites and in Golgi (Takemoto-Kimura et al., 2007) (Fig. 4A and Supplemental Fig. 4). A
dendritic raft-targeted mutant of CaMKIα, GFP-CaMKIα+Cterm (Iαraft-res), was unable to
rescue the axonal impairment in CaMKIα knockdown neurons (Fig. 4B). A cytoplasmic, raft-
excluded mutant of CaMKIγ/CL3, namely CaMKIγ/CL3ΔCterm (Iγcyto), had no ability, either
(Fig. 4B), contrary to our expectations. Thus surprisingly, CaMKI-mediated selectivity of
neurite growth might not be simply determined by the localization of a CaMKIα or CaMKIγ
in or out of the membrane rafts.
To further confirm this, the chimeras were expressed in the background of CaMKIγ/CL3-
knockdown neurons. Expression of an RNAi-resistant WT-CaMKIγ/CL3 (Iγres) rescued the
dendritic impairment, while WT-CaMKIα (Iα) promoted axonal growth without an effect on
dendrite impairment (Fig. 4C). Again however, neither a freely diffusible CaMKIγ/
CL3ΔCterm (Iγcyto-res), nor a raft-targeted CaMKIα, CaMKIα+Cterm (Iαraft), had any effect
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(Fig. 4C). Furthermore, forced expression of CaMKIα, CaMKIγ, and CaMKIα/γ chimeras in
a naïve background revealed that total axonal length was stimulated only by an increase in
CaMKIα (Fig. 4D). Together, these data provide strong functional evidence in support of the
notion that CaMKK-CaMKIα and CaMKK-CaMKIγ are not duplicative mechanisms with
simply altered targeting of downstream kinases, but are genuinely segregated cascades that are
divergent at the level of kinase substrate specificity.
GABA is one of the physiological ligand acting upstream of CaMKIα to promote axonal
growth during early stages of cortical development
The biological significance of this specificity could be demonstrated if the physiological signal
triggering the axonogenic effect of CaMKIα was identified. To this end, we searched for a
potential extracellular ligand which induced intracellular calcium elevation and potently
stimulated axonal growth. We found that muscimol, a GABAA receptor agonist with a known
excitatory action during perinatal development (Owens et al., 1996; Represa and Ben-Ari,
2005), specifically promoted elongation of axons, but not of dendrites, in cultured cortical
neurons (Fig. 5A, B). Under the same conditions, we confirmed that BDNF had a
complementary growth effect largely selective for dendrites (Takemoto-Kimura et al., 2007).
To test the extent of requirement for GABA, we added bicuculline, a GABAA receptor
antagonist, in the medium and found that axonal growth was rather selectively impaired (Fig.
6A). Furthermore, we confirmed that muscimol application triggered a strong Ca2+ influx in
our cortical neurons (Fig. 6B, C). In keeping with this, forced expression of KCC2, a neuronal
K+/Cl- co-transporter that lowers intracellular Cl- concentration, and which is up-regulated
during development to convert the GABA action from excitation to inhibition (Rivera et al.,
1999), impaired both constitutive and muscimol-stimulated axonal growth (Supplemental Fig.
5). Pharmacological blockade of all CaM kinases using KN-93 (Supplemental Fig. 6), or of
CaMKK using STO-609 (Fig. 6D), completely blocked the axonogenic muscimol effect.
CaMKIα RNAi (shIα), but not CaMKIγ/CL3 RNAi (shIγ), selectively impaired muscimol-
stimulated axonal growth (Fig. 6E), and this effect was rescued by co-expressing an
shCaMKIα-resistant CaMKIα WT (IαWTres) , but not CaMKIγ/CL3 WT (IγWT) (Fig. 6F).
Thus a CaMKK-CaMKIα cascade may critically mediate GABAA-stimulated axon outgrowth
during the early development of a cortical neuron.
Contribution of CaMKIα in fine-tuning axonal pathfinding in vivo
We finally tested the in vivo relevance of these findings by investigating the function of
CaMKIα during activity-dependent cortical wiring in vivo. The callosal axons that originate
from layer II/III pyramidal neurons of the somatosensory cortex are known to elongate and
target themselves to the border between the S1 and S2 areas of the contralateral cortex, where
they suddenly turn and grow into the cortical layers and develop their terminal branches mainly
at layers II-III and V. Previous reports demonstrated that reduction of neuronal excitability by
overexpression of an inwardly rectifying potassium channel, Kir2.1, impaired such layer-
specific development of the terminal branches in the visual cortex (Mizuno et al., 2007) and
in the somatosensory cortex (Wang et al., 2007). Furthermore, premature elimination of
excitatory GABA drive by forced expression of KCC2 or knockdown of NKCC1 in newly
born cortical neurons dramatically perturbed the morphological maturation of the dendrites
(Cancedda et al., 2007; Wang and Kriegstein, 2008), or of the terminal callosal axon branches
(H.M. , T. H., Y.T., unpublished data).
If the morphogenetic effect of excitatory GABA required Ca2+ signalling, could the CaMKK-
CaMKIα pathway perhaps mediate activity-dependent control of callosal axonal extension?
To test this, CaMKIα was knockdowned in the somatosensory layer II/III neurons by in utero
electroporation at E15.5, and an effect on axonal growth was examined. At P16, control neurons
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terminated their axons into a restricted region (border of S1/S2 area) in the contralateral cortex
and extensively developed their terminal branches into layers II/III and V (Fig. 7A).
CaMKIα-knockdown neurons extended interhemispheric axonal projections in the white
matter, suggesting the CaMKIα may not be absolutely required for midline crossing and
progression of axon fibers (Fig. 7B). However, their terminal axonal extension into the cortical
layers was severely diminished, especially in layers II/III (Fig. 7C, D). These results indicate
a developmentally critical role of CaMKIα in activity-dependent regulation of cortical
connectivity in vivo.
Discussion
Differential control of cortical axonogenesis and dendritogenesis by activation of CaMKIα
and CaMKIγ/CL3
In a previous work (Takemoto-Kimura et al., 2007), we showed that a lipid-modified CaM
kinase CaMKIγ/CL3 (a membrane-anchored CaMKI isoform) was directed to the dendrites
upon raft insertion and could potently promote early dendritic development, with little effect
on axon outgrowth, in cultured cortical neurons. In striking contrast to CaMKIγ/CL3, we here
demonstrate that a cytosolic sister kinase, CaMKIα, has a complementary role: it has little role
in dendritogenesis, but is necessary and sufficient to promote axonogenesis in the same
preparation. Additionally, our present work established that CaMKIα regulates axonal
extension in vivo. Further rigorous quantitative studies are awaited to establish the potential
role of other CaMKK-CaMK signaling pathways in cortical neuritogenesis in general.
How can such specificity of axonal / dendritic growth be regulated by two separate yet
structurally resembling kinases lying downstream of the same CaMKKs? The chimeric kinase
experiments (Fig. 4) strongly suggested that the diverging kinase substrate specificities and
the dissimilarity in subcellular localization (cytosol vs dendritic rafts) might provide a basis
for the strikingly differential effect of CaMKIα and CaMKIγ/CL3 during axonal and dendritic
development. In support of this functional segregation between the two distinct CaMKK-
CaMKI cascades, we identified an extracellular ligand, GABA, which specifically stimulated
axonal growth via CaMKIα (this study), while BDNF selectively promoted dendritic growth
via CaMKIγ (Takemoto-Kimura et al., 2007), during an early developmental stage of cortical
neurons.
In principle, BDNF could rather selectively act on dendrites in part because of the strong
affinity of the active TrkB receptor to lipid rafts (Suzuki et al., 2004), which are enriched on
dendrites. At this point, however, how GABA stimuli could possibly generate an axon-specific
effect remains rather unclear, although preliminary Ca2+ imaging experiments indicated that
GABAA stimulation might trigger growth cone-localized Ca2+ transients (S.K., H.F., S.T-K.
and H.B., unpublisehd data). It is noteworthy that many potential in vitro substrates of
CaMKIα have previously been associated with axonal or presynaptic functions. These include
synapsin I (Nairn and Greengard, 1987), myosin II regulatory light chain (MRLC) (Suizu et
al., 2002), Numb and Numbl (Tokumitsu et al., 2005), microtubule affinity regulating kinase
2 (MARK2/Par-1b) (Uboha et al., 2007), and β Pak-interacting exchange factor (βPIX)
(Saneyoshi et al., 2008). While some of these known substrates of CaMKI may potentially
underlie a part of early axonal growth, further work is clearly needed to fully elucidate how an
axonogenic substrate may be activated via phosphorylation by CaMKIα.
A pivotal role for a GABA-driven CaMKK-CaMKIα cascade in controlling axonal
morphogenesis during early development
In this work, we identified a crucial role for GABA in controlling cortical axon outgrowth
during early development via a CaMKK-CaMKIα cascade. In immature cortical neurons, what
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is the mechanism by which GABA can stimulate axonal development in a CaMKI-dependent
manner? Recent studies showed that GABAA receptors activation has potent excitatory effects
in immature, but not in mature, neurons (Ben-Ari et al., 2007). The excitatory action of GABA
was demonstrated to be caused by a high basal Cl- concentration in immature neurons, due to
a high amount of the Na+-K+-2Cl- cotransporter (NKCC1) which favorizes Cl- influx, while
the K+-Cl-cotransporter (KCC2) largely responsible for Cl- efflux is still low in expression
(Payne et al., 2003). Because of elevated intracellular Cl- concentration in immature neurons,
GABAA receptors activation thus induces depolarization (Ben-Ari et al., 2007), thereby likely
triggering the opening of voltage-gated Ca2+ channels, which then generates enough Ca2+
influx leading to CaMKK-CaMKIα activation.
During early development, it is now known that GABA controls a variety of biological
processes. Our work has only addressed the significance of the CaMKK-CaMKIα cascade in
GABA-mediated cortical axonogenesis during the perinatal period. Whether other GABA-
regulated processes may also be mediated by CaMKIα clearly remains to be investigated. For
instance, the process of cortical migration has also been reported to be regulated by GABA
through signal transduction pathways involving Ca2+, both in vitro (Behar et al., 1996; Behar
et al., 1998; Behar et al., 2000) and in vivo (Heck et al., 2007). Interestingly, treatment with
calmidazolium, an inhibitor of calmodulin, reduces the migration rate in cerebellar granule
cells (Kumada and Komuro, 2004). Further studies are needed to determine whether the
CaMKK-CaMKIα cascade may play additional roles in such developmental processes as well.
A CaMKK-CaMKIα pathway may regulate fine-sculpting of cortical wiring
We here established the critical importance of an axonogenic GABA-CaMKK-CaMKIα
pathway during early development in vitro. Moreover, this study indicated that CaMKIα
regulated activity-dependent extension of terminal cortical axons in vivo. Interestingly,
premature elimination of excitatory GABA action by forced expression of KCC2 in newly born
cortical neurons dramatically perturbed the morphological maturation of the dendrites
(Cancedda et al., 2007), or of the terminal callosal axon branches (H.M, T.H., and Y.T.,
unpublished data). Our present findings thus uncover an unexpected role of the CaMKK-
CaMKIα cascade as one key mechanism in GABA-driven activity-dependent regulation of
cortical connectivity. More studies are needed to establish whether and how other Ca2+-
mobilizing signals (e.g. BDNF) may spatially and temporally interact and perhaps cooperate
with such an axonogenic GABA-CaMKK-CaMKIα pathway. Finally, our data lend support to
the existence of a perinatal time window of structural refinement, during which spontaneous
Ca2+ signalling regulated by trophic factors, guidance signals and ambient neurotransmitters,
such as BDNF or GABA, critically fine-tunes cortical connectivity, perhaps even prior to the
receipt of the earliest sensory cues.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. CaMKK-dependent CaMK cascades control cortical axonal and dendritic growth
(A, B) A scattered plot (orthogonal plot) of datapoints (A) and averages (B) for both axonal
and dendritic lengths obtained of individual neurons. Black circles, wildtype (WT). Blue
triangles, Iγ/CL3 knockout (Iγ/CL3 KO). Red squares, CaMKKα/β-double knockout (DKO).
Number of neurons: WT, n = 52; Iγ/CL3 KO, n = 44; DKO, n = 52. a) Axon, p<0.001; Dendrite,
p<0.001. b) Dendrite, p<0.01 (one-way ANOVA with Tukey’s test comparison with WT).
(C, D) Cumulative probability analysis for total axonal length (C) and total dendritic length
(D) in neurons from WT, DKO, and Iγ/CL3 KO mice. Number of neurons: WT, n = 52; DKO,
n = 52; Iγ/CL3 KO, n = 44. **, p < 0.01; ***, p<0.001, Kolmogorov-Smirnov test comparison
with WT.
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(E, F) Cortical neurons (2 days in vitro) from CaMKKα/β-double knockout (DKO), mice (F)
showed impaired growth of axons (arrowheads) and dendrites (arrows) as compared with
neurons from wildtype (WT) mice (E). Bar, 25 μm.
(G) Treatment with KN-93, a general CaMK inhibitor, and STO-609, a blocker of CaMKKα/
β, the upstream kinases of all CaMKI/IV, from 6 h to 48 h after plating impaired both axonal
(arrowheads) and dendritic (arrows) growth. Scale bar, 50 μm. (H) An orthogonal plot shows
a quantitative analysis of axonal and dendritic morphometric parameters from each neuron.
Number of neurons: DMSO, n = 48; KN-93, n = 43; STO–609, n = 48. a), b) Axon, p<0.001;
Dendrite, p<0.001 (one-way ANOVA with Tukey’s test comparison with DMSO).
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Figure 2. Knockdown of CaMKIα specifically impairs axonal but not dendritic growth
(A) Efficient downregulation of exogenous GFP-CaMKIα was achieved by a CaMKIα-
targeted shRNA vector (shCaMKIα), but not by a control vector (shNega), in rat cortical
neurons. The mRFP1 expression, which was driven by a dual promoter in a pSUPER+mRFP1
vector, remained unchanged. Bar, 50 μm.
(B) Knockdown of endogenous CaMKIα was evaluated by Western blot analysis using an anti-
CaMKIα antibody. Rat cortical neurons were transfected with pSUPER-shNega or pSUPER-
shCaMKIα by electroporation and the cells were lysed at 2 DIV. shCaMKIα suppressed
endogenous CaMKIα while the control mRFP1 expression level remained unchanged.
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(C, D) shCaMKIα-expressing rat cortical neurons (shCaMKIα) (D) showed impaired axonal
growth (arrowheads), while the dendritic morphology was spared (arrows) as compared with
neurons from shNega-expressing rat cortical neurons (shNega) (C). Bar, 25 μm.
(E) An orthogonal plot of averaged data; n = 15 for all groups. a) Axon, p<0.001. b) Dendrite,
p<0.001 (one-way ANOVA with Tukey’s test comparison with shNega). Bar, 25 μm.
(F) Introduction of shCaMKIα-resistant wild-type GFP-CaMKIα WTres) successfully rescued
the axonal defect elicited by shCaMKIα. In contrast, an shCaMKIα-resistant kinase-inactive
GFP-CaMKIα (a K49Ares point mutant) was unable to rescue the shCaMKIα phenotype. n =
15 for all groups. a), b) Axon, p<0.001 (one-way ANOVA with Tukey’s test comparison with
shNega + mock).
Ageta-Ishihara et al. Page 17
J Neurosci. Author manuscript; available in PMC 2010 April 28.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 3. A specific role for a CaMKK-CaMKIα cascade in promoting axonal growth in cortical
neurons
(A) Representative images of rat cortical neurons transfected with GFP-CaMKIα. Bar, 50 μm.
(B) Overexpression of CaMKIα and CaMKIγ facilitated axonal and dendritic growth,
respectively. n = 15 for all groups. a) Axon, p<0.001, b) Dendrite, p <0.05 (one-way ANOVA
with Tukey’s test comparison with mock).
(C) The axonal growth defect in DKO mice was selectively rescued by co-expression of a
constitutively active CaMKIα (CaMKIαCA), but not by a wild-type CaMKIα (CaMKIαWT);
the dendritic growth defect was left unaltered. n = 15 for all groups. a) Axon, p<0.01; Dendrite,
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p<0.05, b) Axon, p<0.01; Dendrite, p< 0.001, c) Dendrite, p<0.01 (one-way ANOVA with
Tukey’s test comparison with WT + mock).
(D) Only the axonal growth defects due to STO-609 treatment were rescued by expression of
a constitutively active CaMKIα (CaMKIαCA), but not of a wild-type CaMKIα CaMKIαWT).
Dendritic growth defects remained unchanged. n = 15 for all groups. a), b) Axon, p<0.001;
Dendrite, p<0.001, c) Dendrite, p<0.001 (one-way ANOVA with Tukey’s test comparison with
DMSO + mock).
(E) Both axonal and dendritic growth defects due to STO-609 treatment were rescued by
introducing an STO-609-resistant CaMKKβ mutant (V269F), but not of a CaMKKβ-WT. n =
15 for all groups. a), b) Axon, p<0.001; Dendrite, p<0.01 (one-way ANOVA with Tukey’s test
comparison with vehicle + mock).
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Figure 4. Functional segregation of CaMKK-CaMKIα and CaMKK-CaMKIγ cascades
(A) The domain structures and subcellular localizations of CaMKIα (Iα), CaMKIγ/CL3 (Iγ)
and their chimeras. GFP- CaMKIα (Iα), CaMKIγ/CL3 (Iγ) and their chimeras distribution
detected by anti-GFP immunostaining showed co-localization with a Golgi marker, GM130.
GFP- Iγ and Iαraft-res signals were also enriched within Golgi (arrowheads). Single
representative confocal sections are shown for Golgi localization. GFP-Iγ and -Iαraft-res
fluorescence was retained after detergent treatment in a punctate manner in 2 DIV cortical
neurons along the dendrites, demonstrating a sizable portion of detergent-resistant GFP-Iγ and
Iαraft-res in the dendritic rafts. Line scans of pixel fluorescence, carried out within a chosen
field of a 15 μm dendritic segments. Bar, 50 μm (right), 5 μm (middle), 100 (left) μm.
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(B) Neither Iγ, Iαraft-res, nor Iγcyto were able to rescue the axonal phenotype due to knockdown
of CaMKIα. n = 15 for all groups. a), b), c) Axon, p<0.001; d) Axon, p<0.001, Dendrite, p<0.01
(one-way ANOVA with Tukey’s test comparison with shNega + mock).
(C) Neither Iα, Iαraft nor Iγcyto-res were able to rescue the dendritic phenotype due to knockdown
of CaMKIγ/CL3. n = 15 for all groups. a), c), d) Dendrite, p<0.001; b) Axon, p<0.001, Dendrite,
p<0.001 (one-way ANOVA with Tukey’s test comparison with shNega + mock).
(D) Overexpression of CaMKIα specifically increased axon length in cortical neurons. n = 15
for all groups. n = 15 for all groups. a) Axon, p<0.05; b), Dendrite, p<0.001 (one-way ANOVA
with Tukey’s test comparison with mock).
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Figure 5. Muscimol, a GABAA receptor agonist, specifically stimulates elongation of axons in
cultured cortical neurons
(A, B) Representative images (A) and ensemble data (B) of immature cortical neurons treated
with either muscimol (a GABAA receptor agonist) or BDNF. Muscimol significantly promoted
axonal growth (arrowheads). In contrast, BDNF had no effect on axons, but mainly affected
dendrites. Scale bar, 50 μm. n = 15 for all groups. a) Axon, p<0.001, b) Dendrite, p<0.01 (one-
way ANOVA with Tukey’s test comparison with vehicle).
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Figure 6. Activation of GABAA receptors promotes axonal growth via the CaMKK-CaMKIα
pathway in immature cortical neurons
(A) Bicuculline, a GABAA receptor antagonist, blocked axonal growth. n = 15 for all
groups. a) Axon, p<0.001; (Student t-test comparison with vehicle).
(B) Embryonic cortical neurons (1 DIV) were loaded with a calcium indicator, Fluo-4AM, and
calcium responses were measured by time-lapse imaging. A green fluorescence image was
overlaid on a DIC image. Colored boxes indicate the location of cells shown in (C). Scale bar,
50 μm.
(C) Representative calcium responses in individual cells after muscimol administration. Three
different types of calcium responses were revealed (green, blue, and red). An averaged response
from 10 cells in a microscopic field is revealed in black.
(D) Both basal and muscimol-stimulated axonal growths were suppressed with STO-609, a
specific blocker of CaMKKα/β. n = 15 for all groups. (Axon: two-way ANOVA, muscimol
effect, F1,56 = 14.38, p = 0.0004; drug effect, F1,56 = 225.63, p<0.0001; muscimol × drug,
F1,56 = 15.79, p = 0.0002). (Dendrite: two-way ANOVA, muscimol effect, F1,56 = 0.39, p =
0.5336; drug effect,F1,56 = 105.76, p<0.0001; muscimol × drug, F1,56 = 0.13, p =
0.7199). a), b) Axon, p<0.001 (comparison with vehicle + DMSO), c) Axon, p<0.001
(comparison with muscimol + DMSO), n.s. (comparison with vehicle + STO).
(E) CaMKIα knockdown quantitatively inhibited axonal growth induced by muscimol
treatment, to an extent similar to that obtained with STO-609. n = 15 for all groups. (Axon:
two-way ANOVA, muscimol effect, F1,84 = 66.44, p<0.0001; RNAi effect, F2,84 = 168.04,
p<0.0001; muscimol × RNAi, F2,84 = 19.96, p<0.0001). (Dendrite: two-way ANOVA,
muscimol effect, F1,84 = 0.23, p = 0.6305; RNAi effect, F2.84 = 61.58, p<0.0001; muscimol ×
RNAi, F2.84 = 0.01, p = 0.9888). a), b) Axon, p<0.001 (comparison with vehicle +
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shNega), c) Axon, p<0.001 (comparison with muscimol + shNega), n.s. (comparison with
vehicle + shIα), d) Axon, p<0.001 (comparison with vehicle + shIγ), n.s. (comparison with
muscimol + shNega).
(F) Introduction of shCaMKIα-resistant wild-type GFP-CaMKIα (WTres) specifically rescued
the suppression of muscimol-induced axonal growth triggered by knockdown of CaMKIα. n
= 15 for all groups. a) Axon, p<0.001, Dendrite, n.s.; b) Axon, n.s., Dendrite, p<0.001 (one-
way ANOVA with Tukey’s test comparison with muscimol + shIα + mock).c) Axon, n.s.,
Dendrite, p<0.001 (t test comparison with muscimol + shIγ + mock).
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Figure 7. Knockdown of CaMKIα impairs terminal extension of callosal axons in vivo
(A) A control coronal section was obtained near the posterior end of the corpus callosum, from
a P16 pup electroporated in utero with pSUPER-shNega and pCAG- EGFP on E15.5. The
somatodendritic regions of layer II/III neurons were strongly labeled (asterisks) in the
somatosensory cortex, from which callosal axons projected towards the contralateral cortical
areas at the S1/S2 border region (arrowhead). Bar, 1 mm. CC, corpus callosum; Hi,
Hippocampus; Th, Thalamus.
(B) Terminal extension of callosal axons into the contralateral cortical layers was severely
disrupted in CaMKIα-knockdown neurons (shKIα), although axons were able to reach the
white matter (WM) beneath S1/S2 area (arrowhead). Bar, 1 mm.
(C) Axonal extension and terminal branch arborisation were strongly impaired in layers II/III
in CaMKIα-knockdown neurons, as illustrated by the magnified images of GFP marker
showing the total axonal volumes present in the cortical layers (in pseudocolor), or by a one-
dimensional fluorescence intensity profile analysis. Bar: 200 μm.
(D) Quantification of the cortical wiring defect due to an aberrant terminal axon extension in
the cortex. Two independent RNAi constructs (shKIα and shKIα #2) gave similar results.
**p<0.01 (one-way ANOVA with Tukey’s test comparison with shNega).
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